[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global and United States Liposomes Drug Delivery Market Research by Company, Type & Application 2013-2025

April 2018 | 98 pages | ID: GAFC77C89E2EN
HeyReport

US$ 2,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

Market Segment as follows:

By Type
  • Liposomal doxorubicin
  • Liposomal Amphoteracin B
  • Liposomal Paclitaxel
  • Others
By Application
  • Fungal Infection Therapy
  • Cancer Therapy ( Tumor therapy)
  • Others
By Company
  • Johnson & Johnson
  • Gilead Sciences
  • Luye Pharma
  • Sun Pharmaceutical
  • Pacira
  • Fudan-Zhangjiang
  • Sigma-Tau Group
  • Teva Pharmaceutical
  • CSPC
  • Novartis
  • Crucell
  • Celsion Corporation
  • Kingond Pharm
  • Shanghai New Asia
  • Spectrum Pharmaceuticals
The main contents of the report including:

Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 MARKET OVERVIEW

1.1 Market Segment Overview
  1.1.1 Product Definition
  1.1.2 Market by Type
    1.1.2.1 Liposomal doxorubicin
    1.1.2.2 Liposomal Amphoteracin B
    1.1.2.3 Liposomal Paclitaxel
    1.1.2.4 Others
  1.1.3 Market by Application
    1.1.3.1 Fungal Infection Therapy
    1.1.3.2 Cancer Therapy ( Tumor therapy)
    1.1.3.3 Others
1.2 Global and Regional Market Size
  1.2.1 Global Overview
  1.2.2 United States Overview

2 GLOBAL AND REGIONAL MARKET BY COMPANY

2.1 Global
  2.1.1 Global Sales by Company
  2.1.2 Global Price by Company
2.2 United States
  2.2.1 United States Sales by Company
  2.2.2 United States Price by Company

3 GLOBAL AND REGIONAL MARKET BY TYPE

3.1 Global
  3.1.1 Global Sales by Type
  3.1.2 Global Price by Type
3.2 United States
  3.2.1 United States Sales by Type
  3.2.2 United States Price by Type

4 GLOBAL AND REGIONAL MARKET BY APPLICATION

4.1 Global
  4.1.1 Global Sales by Application
  4.1.2 Global Price by Application
4.2 United States
  4.2.1 United States Sales by Application
  4.2.2 United States Price by Application

5 REGIONAL TRADE

5.1 Export
5.2 Import

6 KEY MANUFACTURERS

6.1 Johnson & Johnson
  6.1.2 Company Information
  6.1.2 Product Specifications
  6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Gilead Sciences
  6.2.1 Company Information
  6.2.2 Product Specifications
  6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Luye Pharma
  6.3.1 Company Information
  6.3.2 Product Specifications
  6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Sun Pharmaceutical
  6.4.1 Company Information
  6.4.2 Product Specifications
  6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Pacira
  6.5.1 Company Information
  6.5.2 Product Specifications
  6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Fudan-Zhangjiang
  6.6.1 Company Information
  6.6.2 Product Specifications
  6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Sigma-Tau Group
  6.7.1 Company Information
  6.7.2 Product Specifications
  6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Teva Pharmaceutical
  6.8.1 Company Information
  6.8.2 Product Specifications
  6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 CSPC
  6.9.1 Company Information
  6.9.2 Product Specifications
  6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Novartis
  6.10.1 Company Information
  6.10.2 Product Specifications
  6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Crucell
6.12 Celsion Corporation
6.13 Kingond Pharm
6.14 Shanghai New Asia
6.15 Spectrum Pharmaceuticals

7 INDUSTRY UPSTREAM

7.1 Industry Chain
7.2 Raw Materials

8 MARKET ENVIRONMENT

8.1 SWOT
8.2 Porter's Five Forces

9 CONCLUSION

LIST OF TABLES

Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson
Table Sales Revenue, Volume, Price, Cost and Margin of Gilead Sciences
Table Sales Revenue, Volume, Price, Cost and Margin of Luye Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Sun Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Pacira
Table Sales Revenue, Volume, Price, Cost and Margin of Fudan-Zhangjiang
Table Sales Revenue, Volume, Price, Cost and Margin of Sigma-Tau Group
Table Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of CSPC
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Volume, Price, Cost and Margin of Crucell
Table Sales Revenue, Volume, Price, Cost and Margin of Celsion Corporation
Table Sales Revenue, Volume, Price, Cost and Margin of Kingond Pharm
Table Sales Revenue, Volume, Price, Cost and Margin of Shanghai New Asia
Table Sales Revenue, Volume, Price, Cost and Margin of Spectrum Pharmaceuticals

LIST OF FIGURES

Figure Liposomal doxorubicin Market Size and CAGR 2013-2017 (Million USD)
Figure Liposomal doxorubicin Market Size and CAGR 2013-2017 (Volume)
Figure Liposomal doxorubicin Market Forecast and CAGR 2018-2025 (Million USD)
Figure Liposomal doxorubicin Market Forecast and CAGR 2018-2025 (Volume)
Figure Liposomal Amphoteracin B Market Size and CAGR 2013-2017 (Million USD)
Figure Liposomal Amphoteracin B Market Size and CAGR 2013-2017 (Volume)
Figure Liposomal Amphoteracin B Market Forecast and CAGR 2018-2025 (Million USD)
Figure Liposomal Amphoteracin B Market Forecast and CAGR 2018-2025 (Volume)
Figure Liposomal Paclitaxel Market Size and CAGR 2013-2017 (Million USD)
Figure Liposomal Paclitaxel Market Size and CAGR 2013-2017 (Volume)
Figure Liposomal Paclitaxel Market Forecast and CAGR 2018-2025 (Million USD)
Figure Liposomal Paclitaxel Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Fungal Infection Therapy Market Size and CAGR 2013-2017 (Million USD)
Figure Fungal Infection Therapy Market Size and CAGR 2013-2017 (Volume)
Figure Fungal Infection Therapy Market Forecast and CAGR 2018-2025 (Million USD)
Figure Fungal Infection Therapy Market Forecast and CAGR 2018-2025 (Volume)
Figure Cancer Therapy ( Tumor therapy) Market Size and CAGR 2013-2017 (Million USD)
Figure Cancer Therapy ( Tumor therapy) Market Size and CAGR 2013-2017 (Volume)
Figure Cancer Therapy ( Tumor therapy) Market Forecast and CAGR 2018-2025 (Million USD)
Figure Cancer Therapy ( Tumor therapy) Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Liposomes Drug Delivery Market Size and CAGR 2013-2017 (Million USD)
Figure Global Liposomes Drug Delivery Market Size and CAGR 2013-2017 (Volume)
Figure Global Liposomes Drug Delivery Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Liposomes Drug Delivery Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Liposomes Drug Delivery Market Size and CAGR 2013-2017 (Million USD)
Figure United States Liposomes Drug Delivery Market Size and CAGR 2013-2017 (Volume)
Figure United States Liposomes Drug Delivery Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Liposomes Drug Delivery Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Liposomes Drug Delivery SWOT List
Figure Healthcare & Medical Porter's Five Forces


More Publications